Fifth Third Bancorp
AQST icon

Fifth Third Bancorp’s Aquestive Therapeutics AQST Stock Holding History

Fifth Third Bancorp’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.15K Hold
1,000
– – ﹤0.01% 3906
2025
Q4 		$6.46K Hold
1,000
– – ﹤0.01% 2255
2025
Q3 		$5.59K Buy
+1,000
New +$4.32K ﹤0.01% 2302

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fifth Third Bancorp's AQST Position: Q1 2026 in Review

Fifth Third Bancorp held its Aquestive Therapeutics (AQST) position steady in Q1 2026 at 1,000 shares worth $4.15K. The position accounts for ﹤0.01% of the portfolio, ranked #3906.

Fifth Third Bancorp first reported a position in AQST in Q3 2025 and has held it in 3 quarters since. The position peaked at $6.46K in Q4 2025. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Fifth Third Bancorp held 1,000 shares of Aquestive Therapeutics worth $4.15K as of Q1 2026.
  • Fifth Third Bancorp left its Aquestive Therapeutics share count unchanged in Q1 2026.
  • Aquestive Therapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #3906 holding.
  • Fifth Third Bancorp first reported a position in Aquestive Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Fifth Third Bancorp's Aquestive Therapeutics position peaked at $6.46K in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.